Results 231 to 240 of about 826,714 (280)

Impact of Evolocumab on LDL‐Cholesterol and Cardiovascular Outcomes in Patients With Established CVD: Systematic Review and Meta‐Analysis

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
A systematic review and meta‐analysis of 9 randomised controlled trials (67,662 patients) found that evolocumab significantly improved lipid parameters and reduced major adverse cardiovascular events, myocardial infarction, and coronary revascularisation.
Anika Goel   +10 more
wiley   +1 more source

Postoperative Pain Treatment After Pancreatic Surgery: A Systematic Review With Meta‐Analyses and Trial Sequential Analyses

open access: yesEuropean Journal of Pain, Volume 30, Issue 10, November 2026.
ABSTRACT Background Major pancreatic surgery is associated with significant postoperative pain that impairs early mobilisation and recovery. ERAS guidelines for pancreaticoduodenectomy recommend multimodal opioid‐sparing analgesia, with a strong recommendation for epidural analgesia and continuous wound infiltration as an alternative.
Caroline D. Lassen   +5 more
wiley   +1 more source

Concurrent variations of the left renal and gonadal vessels: a case report. [PDF]

open access: yesJ Vasc Bras
Shetty SD   +4 more
europepmc   +1 more source

Quercetin and Cardiovascular Health: An Evidence‐Based Review of Risk Factors and Treatments

open access: yesFood Science &Nutrition, Volume 14, Issue 11, November 2026.
Quercetin is a naturally occurring polyphenolic phytochemical distributed in fruits and vegetables. Quercetin, as a flavonoid, showed significant antioxidant capabilities and potential therapeutic effects on CVD risk factors. Quercetin reduces cardiac hypertrophy and apoptosis in cardiomyocytes by modulating critical signaling pathways.
Mohammad Reza Khazdair   +2 more
wiley   +1 more source

Curative‐Intent Pancreatectomy for Pancreatic Metastasis From Renal Cell Carcinoma 30 Years After Nephrectomy Following Lenvatinib Plus Pembrolizumab Therapy: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Renal cell carcinoma (RCC) is the most common primary site of pancreatic metastases, and complete resection confers a favorable prognosis. Lenvatinib plus pembrolizumab (LEN + PEM) is standard first‐line therapy for advanced RCC; however, induction therapy before resection of pancreatic metastasis has not been reported.
Yuta Kaneko   +9 more
wiley   +1 more source

A partially duplicated left ovarian vein bisected by the left renal artery: Hypothesized embryologic origins and clinical implications. [PDF]

open access: yesUrol Case Rep
Stoecker A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy